A Double-Blind, Comparative, Randomized Clinical Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL After a Single Subcutaneous Injection in Healthy Subjects